Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-25-017213
Filing Date
2025-06-10
Accepted
2025-06-10 16:39:56
Documents
1
Period of Report
2025-06-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 4539
  Complete submission text file 0001127602-25-017213.txt   6135
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Issuer) CIK: 0001520262 (see all company filings)

EIN.: 981007018 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 852 WINTER STREET WALTHAM MA 02451
Business Address
Nichols Christian Todd (Reporting) CIK: 0001813312 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35299 | Film No.: 251037683